Search results
Results from the WOW.Com Content Network
2021: In March, the company announced it would acquire Five Prime Therapeutics and its lead candidate, bemarituzumab, for $1.9 billion. [93] [94] [95] In the same month, Amgen acquired Rodeo Therapeutics for $720 million. [96] [97] The FDA approved Amgen's Lumakras in May for treatment of patients with KRAS-G12C-mutated non-small cell lung ...
On January 4, 2021, it was announced Centene Corporation would acquire the company for $2.2 billion. [12] On January 4, 2022, the acquisition was completed. [13] Centene divested Magellan Rx in 2022 to Prime Therapeutics. [14] Centene announced the sale of Magellan Specialty Health to Evolvent Health in 2022. [15]
This file contains additional information, probably added from the digital camera or scanner used to create or digitize it. If the file has been modified from its original state, some details may not fully reflect the modified file.
The company announced Thursday its new business unit and brand name: Walgreens Specialty Pharmacy. The business "rolls up all Walgreens specialty pharmacy segment assets, including AllianceRx ...
Prime operates 44 acute care hospitals in 14 states. [12] The hospital network has over 45,000 employees and physicians and more than 8,700 patient beds. [2] Prime Healthcare’s national corporate headquarters is located in Ontario, California. [12]
Two River Group Holdings is a New York-based venture capital firm and merchant bank focused on the life science sector. It specializes in investments in life science, biotechnology, and in firms focused on developing preventive and therapeutic technologies for a broad spectrum of disease areas including oncology, cardiovascular disease, neurological disorders, and companion animal health care.
The top ten specialty pharmacies in 2014 were CVS Specialty parent company CVS Health with $20.5B in sales, Express Scripts's Accredo at $15B, Walgreens Boots Alliance's Walgreens Specialty at $8.5B, UnitedHealth Group's OptumRx at $2.4B, Diplomat Pharmacy at $2.1B, Catamaran's BriovaRx at $2.0B, Specialty Prime Therapeutics's Prime ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!